More on RGNX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $11.20 |
|
|||
| Open | $8.99 | ||||
| 52 Wk High | $25.00 | ||||
| 52 Wk Low | $7.07 | ||||
| Day High | $10.24 | ||||
| Day Low | $8.42 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 7,516,273 | ||||
- REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
- Form 424B5 REGENXBIO Inc.
- Regenxbio prices $100M public offering of stock and warrants
- REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants
- Form FWP REGENXBIO Inc. Filed by: REGENXBIO Inc.
- After-Hours Stock Movers: NFLX, ISRG, KO, AA, RGNX
- Form 424B5 REGENXBIO Inc.
- Regenxbio plans $100M common stock public offering
- REGENXBIO Announces Proposed Public Offering of Common Stock
- Form 4 REGENXBIO Inc. For: Dec 31 Filed by: Simpson Curran
Entities mentioned with RGNX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- Morgan Stanley | View Related Stories »
- 13G | View Related Stories »
- Show More...
